Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Lista

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2016
A common challenge in older adults: Classification, overlap, and therapy of depression and dementiaThomas Leyhe, Charles F Reynolds, Tobias Melcher, et al.
Journal of Alzheimer'S Disease : JAD|August 5, 2017
Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's DiseaseEnrica Cavedo, Per Suppa, Catharina Lange, et al.
Plos One|January 4, 2021
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's diseaseGregory Penner, Soizic Lecocq, Anaëlle Chopin, et al.
Ageing Research Reviews|June 21, 2020
Exercise benefits on Alzheimer's disease: State-of-the-sciencePedro L Valenzuela, Adrián Castillo-García, Javier S Morales, et al.
Nature Reviews. Neurology|October 10, 2018
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinicHarald Hampel, Sid E O'Bryant, José L Molinuevo, et al.
Pharmacological Research|December 5, 2024
Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trialsJosé Pinto-Fraga, Celia García-Chico, Simone Lista, et al.
Expert Review of Neurotherapeutics|December 25, 2014
Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the futureHarald Hampel, Lon S Schneider, Ezio Giacobini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2022
Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's diseaseHerman Depypere, Andrea Vergallo, Pablo Lemercier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2017
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the conceptStéphane Epelbaum, Rémy Genthon, Enrica Cavedo, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 15, 2014
DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disordersHans-Jürgen Möller, Borwin Bandelow, Michael Bauer, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2016
A common challenge in older adults: Classification, overlap, and therapy of depression and dementiaThomas Leyhe, Charles F Reynolds, Tobias Melcher, et al.
Journal of Alzheimer'S Disease : JAD|August 5, 2017
Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's DiseaseEnrica Cavedo, Per Suppa, Catharina Lange, et al.
Plos One|January 4, 2021
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's diseaseGregory Penner, Soizic Lecocq, Anaëlle Chopin, et al.
Ageing Research Reviews|June 21, 2020
Exercise benefits on Alzheimer's disease: State-of-the-sciencePedro L Valenzuela, Adrián Castillo-García, Javier S Morales, et al.
Nature Reviews. Neurology|October 10, 2018
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinicHarald Hampel, Sid E O'Bryant, José L Molinuevo, et al.
Pharmacological Research|December 5, 2024
Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trialsJosé Pinto-Fraga, Celia García-Chico, Simone Lista, et al.
Expert Review of Neurotherapeutics|December 25, 2014
Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the futureHarald Hampel, Lon S Schneider, Ezio Giacobini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2022
Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's diseaseHerman Depypere, Andrea Vergallo, Pablo Lemercier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 12, 2017
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the conceptStéphane Epelbaum, Rémy Genthon, Enrica Cavedo, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 15, 2014
DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disordersHans-Jürgen Möller, Borwin Bandelow, Michael Bauer, et al.
Pageof 14